<DOC>
	<DOCNO>NCT01611428</DOCNO>
	<brief_summary>A study ass absolute bioavailability ipragliflozin healthy subject .</brief_summary>
	<brief_title>Absolute Bioavailability Study With Ipragliflozin</brief_title>
	<detailed_description />
	<criteria>Body Mass Index ( BMI ) equal 18.5 less 30.0 kg/m2 Any liver function test upper limit normal . Abnormal pulse and/or blood pressure measurement prestudy visit follow : Pulse &lt; 40 &gt; 90 bpm ; mean systolic blood pressure &gt; 140 mmHg ; mean diastolic blood pressure &gt; 90 mmHg ( blood pressure measurement take triplicate subject rest supine position 5 min ; pulse measure automatically ) A QTc interval &gt; 430 m ( male ) &gt; 450 m ( female ) consistently duplicate measurement , history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsades de pointes , structural heart disease , family history Long QT Syndrome ( LQTS )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Ipragliflozin</keyword>
	<keyword>Healthy</keyword>
	<keyword>Absolute Bioavailability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>